These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8932894)

  • 1. Caudate nucleus morphology in tardive dyskinesia.
    Brown KW; White T; Wardlaw JM; Walker N; Foley D
    Br J Psychiatry; 1996 Nov; 169(5):631-6. PubMed ID: 8932894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI in tardive dyskinesia: shortened left caudate T2.
    Bartzokis G; Garber HJ; Marder SR; Olendorf WH
    Biol Psychiatry; 1990 Dec; 28(12):1027-36. PubMed ID: 1981152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CT scans in tardive dyskinesia.
    Jeste DV; Wagner RL; Weinberger DR; Rieth KG; Wyatt RJ
    Am J Psychiatry; 1980 Feb; 137(2):247-8. PubMed ID: 6101530
    [No Abstract]   [Full Text] [Related]  

  • 4. Caudate atrophy in irreversible tardive dyskinesia (a pneumoencephalographic study).
    Pandurangi AK; Devi V; Channabasavanna SM
    J Clin Psychiatry; 1980 Jul; 41(7):229-31. PubMed ID: 6967063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caudate nucleus area in drug-induced parkinsonism.
    Brown KW; Wardlaw JM; White T; Walker N
    Acta Psychiatr Scand; 1996 Nov; 94(5):348-51. PubMed ID: 9124082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized tomography in tardive dyskinesia. Evidence of structural abnormalities in the basal ganglia system.
    Bartels M; Themelis J
    Arch Psychiatr Nervenkr (1970); 1983; 233(5):371-9. PubMed ID: 6139995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron-emission tomography in tardive dyskinesia.
    Pahl JJ; Mazziotta JC; Bartzokis G; Cummings J; Altschuler L; Mintz J; Marder SR; Phelps ME
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):457-65. PubMed ID: 8555748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI abnormalities in tardive dyskinesia.
    Mion CC; Andreasen NC; Arndt S; Swayze VW; Cohen GA
    Psychiatry Res; 1991 Nov; 40(3):157-66. PubMed ID: 1685788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous dominance and persistent tardive dyskinesia.
    Barr WB; Mukherjee S; Degreef G; Caracci G
    Biol Psychiatry; 1989 Apr; 25(7):826-34. PubMed ID: 2566333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia and dementia.
    Famuyiwa OO; Eccleston D; Donaldson AA; Garside RF
    Br J Psychiatry; 1979 Dec; 135():500-4. PubMed ID: 43754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Computer tomographic studies of patients with neuroleptic-induced disorders of extrapyramidal motor activity].
    Stuckstedte H; Bartels M; Naumann D; Schied HW; Schroth G
    Nervenarzt; 1984 Sep; 55(9):483-7. PubMed ID: 6150448
    [No Abstract]   [Full Text] [Related]  

  • 12. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia.
    Buckley P; O'Callaghan E; Mulvany F; Larkin C; Stack JP; Redmond O; Ennis JT; Thompson P; Waddington JL
    Psychiatry Res; 1995 Aug; 61(2):95-102. PubMed ID: 7480392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study.
    Elkashef AM; Buchanan RW; Gellad F; Munson RC; Breier A
    Am J Psychiatry; 1994 May; 151(5):752-5. PubMed ID: 7909412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
    Brar JS; Parepally H; Chalasani L; Gopalani A; Appel N; Chengappa KN
    Ann Clin Psychiatry; 2008; 20(3):139-44. PubMed ID: 18633740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.
    Scheepers FE; de Wied CC; Hulshoff Pol HE; van de Flier W; van der Linden JA; Kahn RS
    Neuropsychopharmacology; 2001 Jan; 24(1):47-54. PubMed ID: 11106875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment.
    Dalgalarrondo P; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(5):272-7. PubMed ID: 7893773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of the basal ganglia in schizophrenia.
    Mamah D; Wang L; Barch D; de Erausquin GA; Gado M; Csernansky JG
    Schizophr Res; 2007 Jan; 89(1-3):59-71. PubMed ID: 17071057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings.
    Gold JM; Egan MF; Kirch DG; Goldberg TE; Daniel DG; Bigelow LB; Wyatt RJ
    Biol Psychiatry; 1991 Sep; 30(6):587-99. PubMed ID: 1681948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.